Morepen Laboratories Limited (NSE:MOREPENLAB)
64.44
-0.03 (-0.05%)
Jun 6, 2025, 3:30 PM IST
Morepen Laboratories Revenue
In the fiscal year ending March 31, 2025, Morepen Laboratories had annual revenue of 18.30B INR with 7.52% growth. Morepen Laboratories had revenue of 4.70B in the quarter ending March 31, 2025, with 10.75% growth.
Revenue
18.30B
Revenue Growth
+7.52%
P/S Ratio
1.92
Revenue / Employee
8.50M
Employees
2,152
Market Cap
35.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 18.30B | 1.28B | 7.52% |
Mar 31, 2024 | 17.02B | 2.80B | 19.68% |
Mar 31, 2023 | 14.22B | -1.34B | -8.60% |
Mar 31, 2022 | 15.56B | 3.58B | 29.87% |
Mar 31, 2021 | 11.98B | 3.40B | 39.57% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
Morepen Laboratories News
- 14 days ago - Morepen Laboratories secures Rs 50 crore loan facility from Qatar National Bank - Business Upturn
- 24 days ago - Morepen Laboratories share price drops 3% as Q4 Ebitda falls 12.6% to Rs 42.3 crore - Business Upturn
- 5 weeks ago - Morepen Laboratories receives SEC clearance for Resmetirom bioequivalence studies - Business Upturn
- 6 weeks ago - Morepen Labs shares rally 7% today on this major update – Know More - Business Upturn
- 6 weeks ago - Morepen Labs launches 4 new drugs in April 2025, eyes Rs 1,000 crore formulation business in 5 years - Business Upturn
- 2 months ago - Morepen Laboratories to add 1,000 medical representatives in major expansion drive - Business Upturn
- 2 months ago - Morepen Laboratories shares rise 2% after China approves Loratadine API - Business Upturn
- 2 months ago - Morepen Laboratories secures CDE China approval for Loratadine API, expanding global reach - Business Upturn